Humacyte names new president and CEO
After raising $250 million in equity since March, Humacyte has named Jeffrey Lawson president and CEO.
Read MorePosted by WRAL News | Jun 20, 2018
After raising $250 million in equity since March, Humacyte has named Jeffrey Lawson president and CEO.
Read MorePosted by WRAL TechWire | Mar 9, 2018
Humacyte, a biotechnology company focusing on technology to grow stable, “off-the-shelf” human tissue replacements, has raised $75 million
Read More